RITA ROMANO has been appointed president of the newly created Quadrant Laboratories LLC division at Quadrant Biosciences Inc., a molecular-diagnostics company. She will primarily be responsible for spearheading the growth of Quadrant’s growing laboratory diagnostics business, which includes the opening of a new lab in partnership with SUNY and Upstate Medical University. The company’s Clarifi […]
RITA ROMANO has been appointed president of the newly created Quadrant Laboratories LLC division at Quadrant Biosciences Inc., a molecular-diagnostics company. She will primarily be responsible for spearheading the growth of Quadrant’s growing laboratory diagnostics business, which includes the opening of a new lab in partnership with SUNY and Upstate Medical University. The company’s Clarifi COVID-19 saliva test, co-developed by Upstate Medical, received emergency-use authorization by the FDA in September 2020. It is currently ranked as the most sensitive COVID-19 saliva test currently on the market, Quadrant Biosciences said. Romano brings 30 years of clinical laboratory experience to Quadrant, most recently as director of the Operations Center at Laboratory Alliance of CNY. In this role, she helped oversee clinical- laboratory services that performed more than 10 million tests a year. Romano earned her bachelor’s degree in medical technology and her master’s degree in strategic leadership from St. Bonaventure University
